EC
AVNS

EntryPoint Capital’s Avanos Medical AVNS Stock Holding History

EntryPoint Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,046
Closed -$243K – 662
2025
Q3 		$243K Buy
21,046
+1,636
+8% +$19.2K 0.09% 466
2025
Q2 		$238K Buy
19,410
+6,752
+53% +$84.9K 0.12% 396
2025
Q1 		$181K Buy
+12,658
New +$198K 0.08% 558
2024
Q2 		– Sell
-5,601
Closed -$112K – 900
2024
Q1 		$112K Buy
5,601
+2,766
+98% +$53.5K 0.1% 353
2023
Q4 		$63.6K Buy
+2,835
New +$58.5K 0.06% 614

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EntryPoint Capital's AVNS Position: Q4 2025 in Review

EntryPoint Capital sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 21,046 shares — an estimated $243K sold.

EntryPoint Capital first reported a position in AVNS in Q4 2023 and held it in 5 quarters. The position peaked at $243K in Q3 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • EntryPoint Capital reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • EntryPoint Capital sold 21,046 Avanos Medical shares in Q4 2025, an estimated $243K.
  • EntryPoint Capital first reported a position in Avanos Medical in Q4 2023 and held it in 5 quarters.
  • EntryPoint Capital's Avanos Medical position peaked at $243K in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.